As of January 22, 2025, Xeris Pharmaceuticals (XERS) has a market cap of $0.49 billion USD. According to our data, Xeris Pharmaceuticals is ranked No.6142 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.49 B |
-2.95%
|
Dec 31, 2024 | $0.51 B |
44.26%
|
Dec 29, 2023 | $0.35 B |
76.69%
|
Dec 30, 2022 | $0.20 B |
-54.61%
|
Dec 31, 2021 | $0.44 B |
-40.45%
|
Dec 31, 2020 | $0.73 B |
-30.21%
|
Dec 31, 2019 | $1.05 B |
-58.53%
|
Dec 31, 2018 | $2.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | XERS Stock Price | * | XERS Shares Outstanding |
= | $3.29 | * | 0.15 B | |
= | $0.49 B |